Future Medicinal Chemistry

Future Medicinal Chemistry

Discipline	Medical chemistry
Language	English
Publication details
History	2009–present
Publisher	Future Medicine Ltd
Frequency	24/year
Impact factor	4.767 (2021)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Future Med. Chem.
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus
CODEN	FMCUA7
ISSN	1756-8919 (print) 1756-8927 (web)
OCLC no.	762952421
Links
Journal homepage

Future Medicinal Chemistry is a peer-reviewed medical journal covering all aspects of medicinal chemistry, including drug discovery, pharmacology, in silico drug design, structural characterization techniques, ADME-Tox investigations, and science policy, economic and intellectual property issues. It was established in 2009 and is published by Future Science. The editors-in-chief are Iwao Ojima (The State University of New York at Stony Brook) and Jonathan Baell (Monash University).

Abstracting and indexing

The journal is abstracted and indexed by BIOSIS Previews, Chemical Abstracts, Chemistry Citation Index, Embase/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2020 impact factor of 3.808.[1]

References

1. "Future Medicinal Chemistry". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.

External links

• Official website